Skip to content

Titanium vs. PEEK Fusion Devices in 1 Level TLIF

A Prospective, Randomized Comparison of Titanium vs. PEEK Fusion Devices in 1 Level TLIF

Status
Enrolling by invitation
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05691062
Acronym
TLIF
Enrollment
80
Registered
2023-01-19
Start date
2024-09-01
Completion date
2028-01-11
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spondylolisthesis, Lumbar Stenosis, Spine Fusion

Brief summary

The objective of this study is to evaluate and follow the clinical and radiographic outcomes of patients undergoing 1 level TLIF randomized to either a titanium or a PEEK spacer to 24 months after surgery.

Detailed description

Transforaminal lumbar interbody fusion (TLIF) remains a common surgical technique for the management of lumbar spondylosis requiring decompression and fusion. The choice of interbody spacer remains dependent on surgeon preference with a variety of options available for use. Two of the most commonly used interbody spacers are made of polyetheretherketone (PEEK) and titanium.1 While both spacers have produced reliable rates of fusion with good clinical outcomes, debate remains as to which interbody spacer is superior. Proponents of PEEK argue that it is radiolucent and has an elastic modulus similar to bone thus decreasing rates of subsidence. However, PEEK is a hydrophobic material that does not integrate with bone. Titanium on the other hand demonstrates osseointegration and may lead to increased rates of fusion.While there are retrospective studies available comparing the two materials, the studies are small and there is a paucity of prospective data comparing the radiographic and clinical outcomes of these spacers. Given the frequency with which these spacers are used, it is important to determine which spacer produces better clinical and radiographic outcomes for patients.

Interventions

DEVICETitanium Fusion Device

Titanium fusion device will be utilized for one-level lumbar fusion.

DEVICEPEEK Fusion Device

PEEK fusion device will be utilized for one-level lumbar fusion.

Sponsors

Twin Cities Spine Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Subjects will be blinded to fusion device.

Intervention model description

Prospective randomized clinical trial with two cohorts.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Patients undergoing 1 level TLIF for the treatment of lumbar stenosis and spondylolisthesis who have failed at least 6 weeks of non-operative treatment. 2. Patients between 18-70 years of age at the time of surgery.

Exclusion criteria

1. Patients under 18 or over 70 years of age at the time of surgery. 2. Patients undergoing more than 1 level of surgery. 3. Patients who have had prior lumbar fusion. 4. Patients requiring surgery for the management of infection, tumor, or trauma. 5. Patients who are pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Fusion Status of 1 level Lumbar TLIF12 months Post-OpAssess fusion status of 1 level Lumbar TLIF by reviewing patient CT Scan completed for study purposes.
Revision SurgeriesUp to 24 months Post-opMonitor and Record Complications and Revision Surgeries

Secondary

MeasureTime frameDescription
Patient Reported Outcome MeasuresPreoperative time frame up to 24 months Post-opData collected from patient self reported outcome tools

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026